News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syngenta AG (SYT) Announces Successful EUR 750 Million Eurobond Issues



3/25/2014 6:45:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Syngenta Announces Successful EUR 750 Million Eurobond Issues

BASEL, Switzerland, March 24, 2014 /PRNewswire/ -- Syngenta announced today the successful issue of EUR 750 million in Eurobonds. This issue comprises a EUR 500 million Eurobond with maturity date in November 2021 and a EUR 250 million Eurobond with maturity date in October 2017.

John Ramsay, CFO, said: "We have taken advantage of current favorable market conditions in order to further enhance our debt maturity profile. These bond issues are part of our normal funding requirements and the positive market reception demonstrates Syngenta's strong credit quality."

Syngenta is one of the world's leading companies with more than 28,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to http://www.syngenta.com

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in or securities of Syngenta AG, Syngenta Finance NV, Syngenta Finance AG or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.

SOURCE Syngenta International AG

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES